Oral arsenic trioxide for treating acute promyelocytic leukaemia: Implications for its worldwide epidemiology and beyond

Overview of attention for article published in Frontiers in oncology, November 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 5 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 7 X posts from 5 X users, with an upper bound of 27,255 followers.

Oral arsenic trioxide for treating acute promyelocytic leukaemia: Implications for its worldwide epidemiology and beyond https://t.co/pIzw6QphUg https://t.co/Fs9C3gv9Lv

21 Dec 2022

Reply Repost Favourite

📖 Review Article: Oral arsenic trioxide for treating acute promyelocytic #leukaemia: Implications for its worldwide #epidemiology and beyond 👨‍⚕️👩‍⚕️ Kumana CR et al Read here 👉 https://t.co/QvLgdJMMaf #HemOnc

19 Dec 2022

Reply Repost Favourite

Oral arsenic trioxide for treating acute promyelocytic leukaemia: Implications for its worldwide epidemiology and beyond #lymphoma #lymsm https://t.co/aSV9iFBooj

15 Dec 2022

Reply Repost Favourite

Oral arsenic trioxide for treating acute promyelocytic leukaemia https://t.co/uvwYGhPuL0

21 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.